Cross Cancer Institute | Clinical Trials Unit

Edmonton, Alberta T6G 1Z2

0 studies enrolling now · 1 studies all time

What they study most

Advanced Metastatic Castration-resistant Prostate Cancer, Prostate Specific Membrane Antigen (PSMA) Expression

Studies at this site

• First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) — Recruiting now